VERU Veru Inc
Company Analysis
Latest News
🔴 Veru Inc is trading 5.6% down today on continued profit-taking after Novo Nordisk deal surge
Veru Inc is trading 5.6% down at $3.21 in after-hours trading as investors continue to take profits following a massive rally triggered by its clinical trial...
🔴 Veru Inc is trading 11.8% down today after profit-taking following its Novo Nordisk deal rally
Veru Inc is trading at $3.73 (-11.82%) as the stock undergoes a sharp pullback following a significant rally in the previous session. • The recent surge was...
🔴 Veru Inc is trading 6.9% down today on profit-taking after its Novo Nordisk agreement surge
Veru Inc is trading at $3.94 (6.9% down) as the stock undergoes normalization and profit-taking following an 88% jump driven by its new clinical supply...
Veru Announces Clinical Supply Agreement with Novo Nordisk for Phase 2b Obesity Trial
Veru Inc. has entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical study. The study will evaluate the...
Veru Landed a Novo Nordisk Deal and Doubled in a Day — But Can a $60 Million Biotech Sustain the Hype?
Shares of Veru Inc. (VERU) are pulling back 10.4% to $3.79 this morning after an explosive rally that saw the stock surge as much as 161% intraday on...
🔴 Veru Inc is trading 10.4% down today on profit-taking after yesterday's 88% surge from a Novo Nordisk deal
Veru Inc is trading 10.4% down at $3.79 as the stock undergoes consolidation and profit-taking following yesterday's massive 88% rally. • The prior-day surge...
Veru stock surges on Novo Nordisk deal for Wegovy obesity trial
Veru Inc. entered a clinical supply agreement with Novo Nordisk for the Phase 2b PLATEAU trial. Novo Nordisk will provide its weight-loss drug Wegovy...